Galina Tsykunova

494 total citations
25 papers, 200 citations indexed

About

Galina Tsykunova is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Galina Tsykunova has authored 25 papers receiving a total of 200 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 9 papers in Oncology and 8 papers in Genetics. Recurrent topics in Galina Tsykunova's work include Platelet Disorders and Treatments (7 papers), Hematopoietic Stem Cell Transplantation (7 papers) and Multiple Myeloma Research and Treatments (6 papers). Galina Tsykunova is often cited by papers focused on Platelet Disorders and Treatments (7 papers), Hematopoietic Stem Cell Transplantation (7 papers) and Multiple Myeloma Research and Treatments (6 papers). Galina Tsykunova collaborates with scholars based in Norway, United States and Denmark. Galina Tsykunova's co-authors include Øystein Bruserud, Håkon Reikvam, Bjørn Tore Gjertsen, Aymen Ahmed, Elisabeth Ersvær, Hanne Fredly, Astrid Olsnes Kittang, Maria Hernandez-Valladares, Randi Hovland and Elise Aasebø and has published in prestigious journals such as Blood, International Journal of Molecular Sciences and British Journal of Haematology.

In The Last Decade

Galina Tsykunova

19 papers receiving 199 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Galina Tsykunova Norway 8 147 103 30 25 21 25 200
Rosa Coll Spain 9 99 0.7× 82 0.8× 21 0.7× 54 2.2× 23 1.1× 20 181
Yusuke Isshiki Japan 9 69 0.5× 98 1.0× 23 0.8× 29 1.2× 10 0.5× 20 162
Maria López‐Pavía Spain 9 108 0.7× 102 1.0× 21 0.7× 31 1.2× 9 0.4× 21 183
Salvatore Serravalle Italy 8 83 0.6× 120 1.2× 34 1.1× 9 0.4× 12 0.6× 15 198
Kristen E. Schratz United States 7 90 0.6× 108 1.0× 13 0.4× 38 1.5× 30 1.4× 10 272
W.-K. Hofmann Germany 7 120 0.8× 159 1.5× 61 2.0× 36 1.4× 13 0.6× 9 268
Orna Steinberg‐Shemer Israel 8 85 0.6× 113 1.1× 17 0.6× 65 2.6× 13 0.6× 30 237
Amritha Varshini Hanasoge Somasundara United States 5 59 0.4× 95 0.9× 40 1.3× 50 2.0× 11 0.5× 6 168
Ying‐Jung Huang Taiwan 9 172 1.2× 134 1.3× 26 0.9× 70 2.8× 14 0.7× 21 243
Viviana Guadagnuolo Italy 6 73 0.5× 69 0.7× 37 1.2× 26 1.0× 7 0.3× 24 158

Countries citing papers authored by Galina Tsykunova

Since Specialization
Citations

This map shows the geographic impact of Galina Tsykunova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Galina Tsykunova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Galina Tsykunova more than expected).

Fields of papers citing papers by Galina Tsykunova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Galina Tsykunova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Galina Tsykunova. The network helps show where Galina Tsykunova may publish in the future.

Co-authorship network of co-authors of Galina Tsykunova

This figure shows the co-authorship network connecting the top 25 collaborators of Galina Tsykunova. A scholar is included among the top collaborators of Galina Tsykunova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Galina Tsykunova. Galina Tsykunova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reikvam, Håkon, et al.. (2025). Infectious complications and the utility of serum and cellular markers of infections in the setting of allogeneic hematopoietic stem cell transplantation. Expert Review of Clinical Immunology. 21(3). 291–303. 1 indexed citations
2.
Tsykunova, Galina, Pål André Holme, Hoa Tran, et al.. (2025). Safety and efficacy of daratumumab in immune thrombocytopenia. Blood Advances. 10(1). 143–154.
3.
Abildgaard, Niels, Galina Tsykunova, Annette Juul Vangsted, et al.. (2023). Intensifying treatment in PET-positive multiple myeloma patients after upfront autologous stem cell transplantation. Leukemia. 37(10). 2107–2114. 1 indexed citations
4.
5.
Haukås, Einar, Galina Tsykunova, Anders Vik, et al.. (2023). Will Survival Improve By Treating Multiple Myeloma Patients at MRD Relapse? the Remnant Study. Blood. 142(Supplement 1). 4755–4755. 2 indexed citations
6.
Garabet, Lamya, Eirik Tjønnfjord, Galina Tsykunova, et al.. (2023). Real-World Use, Effectiveness and Safety of Romiplostim, Eltrombopag and Avatrombopag in Immune Thrombocytopenia: Data from the Norwegian ITP Registry. Blood. 142(Supplement 1). 3952–3952.
7.
Rasmussen, Allan, Einar Haukås, Galina Tsykunova, et al.. (2022). P889: WILL OUTCOME IMPROVE BY TREATING MULTIPLE MYELOMA PATIENTS AT MRD RELAPSE? THE REMNANT STUDY (RELAPSE FROM MRD NEGATIVITY AS INDICATION FOR TREATMENT). HemaSphere. 6. 781–782. 2 indexed citations
8.
Tsykunova, Galina & Waleed Ghanima. (2022). Avatrombopag for the Treatment of Adult Patients with Chronic Immune Thrombocytopenia (cITP): Focus on Patient Selection and Perspectives. Therapeutics and Clinical Risk Management. Volume 18. 273–286. 7 indexed citations
9.
Tsykunova, Galina, Pål André Holme, Tor Henrik Anderson Tvedt, et al.. (2022). PB2313: DARATUMUMAB AS A TREATMENT FOR ADULT IMMUNE THROMBOCYTOPENIA: A PHASE II STUDY WITH SAFETY RUN-IN (THE DART STUDY). HemaSphere. 6. 2182–2183. 4 indexed citations
10.
Bruserud, Øystein, Galina Tsykunova, Maria Hernandez-Valladares, Håkon Reikvam, & Tor Henrik Anderson Tvedt. (2021). Therapeutic Use of Valproic Acid and All-Trans Retinoic Acid in Acute Myeloid Leukemia—Literature Review and Discussion of Possible Use in Relapse after Allogeneic Stem Cell Transplantation. Pharmaceuticals. 14(5). 423–423. 8 indexed citations
11.
12.
Tsykunova, Galina, Pål André Holme, Hoa Tran, et al.. (2021). Daratumumab As a Treatment for Adult Immune Thrombocytopenia: A Phase II Study with Safety Run-in (the DART Study). Blood. 138(Supplement 1). 2088–2088. 10 indexed citations
13.
Tsykunova, Galina, et al.. (2020). Beighton-skår. Tidsskrift for Den norske legeforening. 2 indexed citations
14.
15.
Hovland, Randi, et al.. (2019). Trisomy 8 in acute myeloid leukemia. Expert Review of Hematology. 12(11). 947–958. 27 indexed citations
16.
Tvedt, Tor Henrik Anderson, Randi Hovland, Galina Tsykunova, et al.. (2018). A pilot study of single nucleotide polymorphisms in the interleukin-6 receptor and their effects on pre- and post-transplant serum mediator level and outcome after allogeneic stem cell transplantation. Clinical & Experimental Immunology. 193(1). 130–141. 4 indexed citations
17.
Bruserud, Øystein, Elise Aasebø, Maria Hernandez-Valladares, Galina Tsykunova, & Håkon Reikvam. (2017). Therapeutic targeting of leukemic stem cells in acute myeloid leukemia – the biological background for possible strategies. Expert Opinion on Drug Discovery. 12(10). 1053–1065. 32 indexed citations
18.
Grønningsæter, Ida Sofie, et al.. (2017). Bronchiolitis obliterans syndrome in adults after allogeneic stem cell transplantation-pathophysiology, diagnostics and treatment. Expert Review of Clinical Immunology. 13(6). 553–569. 17 indexed citations
19.
Fredly, Hanne, Elisabeth Ersvær, Astrid Olsnes Kittang, et al.. (2013). The combination of valproic acid, all-trans retinoic acid and low-dose cytarabine as disease-stabilizing treatment in acute myeloid leukemia. Clinical Epigenetics. 5(1). 13–13. 46 indexed citations
20.
Tsykunova, Galina, Håkon Reikvam, Aymen Ahmed, et al.. (2012). Targeting of polo-like kinases and their cross talk with Aurora kinases – possible therapeutic strategies in human acute myeloid leukemia?. Expert Opinion on Investigational Drugs. 21(5). 587–603. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosa Coll Breakdown of academic impact, for papers by Yusuke Isshiki Breakdown of academic impact, for papers by Maria López‐Pavía Breakdown of academic impact, for papers by Salvatore Serravalle Breakdown of academic impact, for papers by Kristen E. Schratz Breakdown of academic impact, for papers by W.-K. Hofmann Breakdown of academic impact, for papers by Orna Steinberg‐Shemer Breakdown of academic impact, for papers by Amritha Varshini Hanasoge Somasundara Breakdown of academic impact, for papers by Ying‐Jung Huang Breakdown of academic impact, for papers by Viviana Guadagnuolo
Rankless by CCL
2026